Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteins

Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteins

US Patent 11135292 · Granted Oct 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

High-affinity Mycobacterium tuberculosis capsule-specific human monoclonal antib2025
Antibodies or antibody-fragments thereof targeting alphaviruses, and composition2025
Multi-specific antibodies for cross-neutralization of multiple filovirus glycopr2024
Multi-specific antibodies for cross-neutralization of multiple filovirus glycopr2024
Multi-specific antibodies for cross-neutralization of multiple filovirus glycopr2024
Engineered PD-1 variants2024
Engineered PD-1 variants2024
High-affinity Mycobacterium tuberculosis capsule-specific human monoclonal antib2023
Engineered PD-1 variants2022
Engineered PD-1 variants2022
Synthetic antibodies to BAX and uses thereof2021
Methods of treating filovirus infections utilizing bispecific antibodies and fus2021